PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q3–2026Q2) · Dividend yield is based on ₩500 per share · Prices as of the 2026-10-02 close
Hecto Innovation's IT service, fintech, and healthcare segments are growing in tandem to deliver record revenue, while stablecoin wallet and payment infrastructure investment emerges as the next growth axis.
2025 consolidated revenue reached KRW 375.8bn (up 17.6% YoY) and operating profit KRW 50.2bn (up 2.7%), both record highs.
First-quarter 2026 revenue topped KRW 100bn for the first time in company history, and cumulative first-half revenue also crossed KRW 200bn for the first time.
Net income attributable to owners has fluctuated sharply by quarter, falling from KRW 11.0bn in Q2 2025 to KRW 4.1bn in Q4 2025 before recovering to KRW 7.0bn in Q2 2026.
The company is expanding into stablecoin infrastructure through its acquisition of blockchain wallet firm WalletOne and its participation in Circle's payment network.
Legislation for Korea's Digital Asset Basic Act has been delayed, leaving regulatory uncertainty around issuance rights and the scope of permitted business.
Hecto Innovation operates through three core business segments: IT information services, fintech, and healthcare. The IT service segment, run directly by the parent company, centers on platform and authentication services and continues to post double-digit growth through new service launches and expanding client bases.
The fintech segment is handled by subsidiary Hecto Financial, whose core offerings include membership-based simple cash payment, virtual accounts, and cross-border settlement for overseas merchants.
The healthcare segment, run by subsidiary Hecto Healthcare, has become the group's reliable cash cow, led by its probiotics brand De Simone.
In the first half of 2026, revenue from IT services, fintech, and healthcare grew 16.8%, 18.3%, and 17.3% year-on-year respectively, reflecting balanced growth without heavy reliance on any single segment.
In September of the prior year, the company acquired a 47.15% stake in blockchain wallet firm WalletOne (formerly Haechi Labs), becoming its largest shareholder and gaining a Virtual Asset Service Provider (VASP) license along with wallet infrastructure including Octet.
In the fintech market, the company competes with simple-payment operators such as NHN KCP and KG Inicis, while the healthcare segment competes with domestic and overseas health-supplement brands.
More recently, the company has paired its core business with consumer-facing services such as the baseball prediction platform Polyball and the weather app Nalssidol, using them to expand user exposure to its digital asset wallet.
| Quarter | Revenue | Operating profit | Op. margin |
|---|---|---|---|
| 2025Q2 | ₩91.8B | ₩13.4B | 14.6% |
| 2025Q3 | ₩95.6B | ₩14.7B | 15.3% |
| 2025Q4 | ₩98.8B | ₩10.4B | 10.5% |
| 2026Q1 | ₩112.3B | ₩14.6B | 13.0% |
| 2026Q2 | ₩102.8B | ₩12.9B | 12.5% |
| Year | Revenue | Operating profit | Net income (parent) | Op. margin | ROE | Debt-to-equity |
|---|---|---|---|---|---|---|
| 2022 | ₩263B | ₩35.6B | ₩29.5B | 13.6% | 21.0% | 86.4% |
| 2023 | ₩288.5B | ₩37.3B | ₩22.6B | 12.9% | 13.4% | 95.4% |
| 2024 | ₩319.5B | ₩48.9B | ₩27.9B | 15.3% | 13.5% | 109.9% |
| 2025 | ₩375.8B | ₩50.2B | ₩30.5B | 13.4% | 13.7% | 122.3% |
Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-08-21
Consolidated revenue in 2025 reached KRW 375.8bn, up 17.6% from KRW 319.5bn in 2024, while operating profit rose 2.7% to KRW 50.2bn, with both figures marking record highs.
However, the operating margin narrowed from 15.3% in 2024 to 13.4% in 2025, reflecting the cost burden from expanded investment in new businesses, as profit growth trailed well behind revenue growth.
Net income attributable to owners rose 9.4% to KRW 30.5bn in 2025 from KRW 27.9bn in 2024, a pace faster than operating profit growth (2.7%) but slower than revenue growth (17.6%).
On a quarterly basis, after posting operating profit of KRW 13.4bn and owner net income of KRW 11.1bn in the second quarter of 2025, the company saw operating profit of KRW 14.7bn and net income of KRW 8.4bn in the third quarter, followed by KRW 10.4bn and KRW 4.1bn in the fourth quarter, with net income decelerating more sharply than operating profit.
The first quarter of 2026 saw a rebound to revenue of KRW 112.3bn and operating profit of KRW 14.6bn, marking the first time quarterly revenue exceeded KRW 100bn, though owner net income of KRW 6.3bn improved from the year-earlier quarter but remained below the second-quarter 2025 level.
In the second quarter of 2026, revenue reached KRW 102.8bn, operating profit KRW 12.9bn, and owner net income KRW 7.0bn; revenue grew 12.0% from KRW 91.8bn a year earlier, but operating profit and net income improved at a more modest pace than revenue.
While revenue and operating profit have continued to set new quarterly records, owner net income has shown greater volatility, likely influenced by new business investment and the growing minority-interest share tied to consolidated subsidiaries.
On the cash flow side, operating cash flow of KRW 100.4bn in 2025 was broadly similar to KRW 106.0bn in 2024, suggesting cash generation has remained relatively stable relative to earnings growth.
Korea's simple-payment and fintech market continues to grow steadily on the back of merchant expansion and rising online transactions, while stablecoins have recently emerged as a new payment infrastructure axis.
The government is pursuing enactment of the Digital Asset Basic Act in the second half of 2026, with provisions expected to include a licensing regime for won-denominated stablecoin issuance, reserve asset requirements, and user protection measures.
However, disagreement between the banking sector and the fintech/platform industry over whether issuance should be restricted to bank-led consortiums has repeatedly delayed the legislative timeline.
Overseas, digital asset wallet firms such as Fireblocks and BitGo have earned high valuations in the institutional custody market, whereas Korea's institutional framework remains at an early stage.
Against this backdrop, Hecto Innovation is combining Hecto Financial's existing payment and settlement infrastructure with WalletOne's wallet technology to build a wallet-to-payment-to-platform structure, and has positioned itself early as Korea's sole digital wallet partner in Circle's Payment Network (CPN) and the Arc stablecoin-focused mainnet testnet.
In the healthcare segment, growth in the probiotics market alongside expanding overseas distribution channels, including in China, is emerging as a new demand driver.
Overall, the company is building infrastructure and partnerships ahead of full domestic institutionalization, leaving the pace and direction of legislation as a key variable for business expansion.
The company continues to identify building a stablecoin ecosystem that organically links wallet, payment, and platform as its core task for 2026.
It plans to strengthen its own B2C app platform while introducing new services developed jointly with WalletOne, and is also conducting a proof of concept for an AI-agent-driven automated stablecoin payment system.
In the healthcare segment, Hecto Healthcare has received approval for an individually recognized functional health-food ingredient after its proprietary probiotics compound was recognized by the Ministry of Food and Drug Safety for body-fat reduction benefits, and the company plans to expand beyond health supplements into the broader healthcare food category.
According to a News1 report from May 2026, a supply contract worth at least KRW 155bn with a Sinopharm affiliate in China is underway, positioning overseas distribution expansion as a medium-term growth driver for the healthcare segment.
Eugene Investment & Securities projected in a May 2026 report that quarterly revenue would remain above KRW 100bn in the second quarter with stable growth continuing, and actual second-quarter revenue of KRW 102.8bn was consistent with that projection.
On the domestic institutionalization front, the government is targeting enactment of the Digital Asset Basic Act in the second half of 2026, and whether it passes within the year along with its provisions on issuance rights remain key variables determining the actual monetization timeline for the stablecoin business.
The company has repeatedly stated its intent to maintain stable profitability from existing operations while continuing to invest in new growth engines, suggesting a structure in which short-term margin pressure from expanded investment and medium-to-long-term business expansion will proceed in parallel.
Owner net income over the most recent four quarters (Q3 2025 to Q2 2026) shows only modest improvement relative to the full-year 2025 level, a trend also reflected in valuation metrics.
Some brokerages have noted that the stock's price-to-book level sits near the lower end of its multi-year trading band, which they cite as a possible sign that the market has not yet fully priced in the value of new growth businesses.
Eugene Investment & Securities stated in a report dated May 11, 2026 that "the target price of KRW 28,000 implies roughly 40% upside from the current share price,
PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-08-21
IT services, fintech, and healthcare all posted growth rates of around 17% in the first half of 2026, growing evenly without reliance on any single segment. Quarterly revenue held above KRW 100bn in both the first and second quarters, sustaining stable top-line expansion. This diversified business structure can help cushion the overall results from weakness in any single segment.
Through the acquisition of WalletOne, the company secured a VASP license and wallet infrastructure, and it participates as Korea's sole digital wallet partner in Circle's Payment Network and the Arc testnet.
Its strategy of combining this with Hecto Financial's existing payment and settlement infrastructure to build a wallet-payment-platform structure is becoming more concrete.
Securing global partnerships ahead of full domestic institutionalization is cited as a factor that could position the company favorably once the market opens.
Centered on its probiotics brand De Simone, the healthcare segment has become a reliable earnings source for the group.
The company recently secured approval for a body-fat-reduction functional ingredient, laying the groundwork for an expanded product lineup, while a large supply contract with a Sinopharm affiliate in China is also broadening its overseas distribution network. If this trend continues, the healthcare segment could keep serving as a stabilizer for overall earnings.
While 2025 revenue grew 17.6%, operating profit rose only 2.7% and owner net income only 9.4%, with profit growth failing to keep pace with revenue growth.
On a quarterly basis as well, owner net income fell from KRW 11.1bn in the second quarter of 2025 to KRW 4.1bn in the fourth quarter, showing greater volatility than operating profit. As long as new business investment continues, this lag in profit growth could persist.
The Digital Asset Basic Act originally targeted passage in the first quarter of 2026 but has been repeatedly delayed due to local elections and disagreements among relevant agencies.
Debate continues over whether issuance should be restricted to bank-led consortiums, meaning the scope of fintech company participation could vary significantly depending on the final legislation.
If institutionalization is delayed further than expected, the monetization timeline for stablecoin-related investment could also be pushed back.
The operating margin fell to 13.4% in 2025 from 15.3% the prior year, and the fourth-quarter 2025 operating margin also declined from the prior quarter. The company attributes this to preemptive investment for new service launches and future growth engines.
If this investment does not translate into results as expected, there is a risk that margin recovery could be delayed.
The final content of the Digital Asset Basic Act, particularly whether stablecoin issuance rights are restricted, could determine the scope of business available to fintech companies.
If issuance is limited to bank-led consortiums, the scope for utilizing infrastructure secured by Hecto Financial and WalletOne could be reduced. If the legislative timeline is delayed again, uncertainty around new business plans could persist longer.
Of the KRW 36.8bn in consolidated net income in 2025, KRW 30.5bn was attributable to owners, with the remainder allocated to minority interests. In a structure that consolidates multiple subsidiaries, earnings volatility at individual subsidiaries can affect the stability of owner net income.
The earnings contribution from newly acquired subsidiaries such as WalletOne remains at an early stage and warrants monitoring.
The simple-payment market has numerous competing fintech operators, and competition for merchant acquisition could affect margins. In the digital asset wallet space, overseas firms such as Fireblocks and BitGo already command high valuations in the institutional custody market, making global competition formidable.
The healthcare segment also continues to face ongoing competition among domestic and overseas health-supplement brands.
The Q3 2026 provisional earnings disclosure is expected — a point to check whether the trend of record quarterly revenue and operating profit continues and whether owner net income growth accelerates.
Whether the National Assembly passes the Digital Asset Basic Act and finalizes provisions on issuance rights — a key variable determining the actual monetization scope of the stablecoin business.
It is worth monitoring the commercialization timeline of new WalletOne–Circle Arc-based services and whether Hecto Financial expands its use of Circle's Payment Network.
A point to check the progress of the supply contract with the Sinopharm affiliate in China and the results of Hecto Healthcare's new brand and functional ingredient expansion.
Hecto Innovation has continued to set new quarterly and annual records for both revenue and operating profit, underpinned by balanced growth across its three core segments of IT information services, fintech, and healthcare.
However, owner net income has not kept pace with revenue and operating profit growth and has shown considerable quarterly volatility, warranting continued attention to how new business investment and expanding minority interests affect earnings flow.
On the stablecoin front, the company has secured relatively advanced infrastructure among domestic peers through its WalletOne acquisition and Circle partnership, but the actual monetization timeline remains uncertain given that Korea's Digital Asset Basic Act and its provisions on issuance rights have not yet been finalized.
The healthcare segment, centered on the De Simone brand and the Sinopharm supply contract, continues to serve as a stable earnings source for the group, and whether this trend persists will be a key variable for future results.
On valuation, various views have been offered by brokerages regarding the stock's price relative to book value, but these reflect judgments made at specific points in time and may change with subsequent earnings and regulatory developments.
Overall, the company is in a phase where business diversification and new growth investment are proceeding simultaneously, with the sustainability of revenue growth, the pace of profit conversion, and progress on domestic institutionalization standing as the key factors that will shape future results.
Report written 2026-09-05 · Data as of 2026-09-04
This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.